Zheyi Yan

446 citations
13 papers · 339 indexed · h-index 10
Topics
Retinal Diseases and Treatments (4 papers)Adipokines, Inflammation, and Metabolic Diseases (3 papers)Phytochemicals and Medicinal Plants (3 papers)
Partner nations
ChinaUnited States

In The Last Decade

Zheyi Yan

12 papers receiving 336 citations

Peers

Zheyi Yan
Comparison fields: 5 of 69
  • Molecular Biology 116
  • Epidemiology 106
  • Physiology 72
  • Cardiology and Cardiovascular Medicine 71
  • Complementary and alternative medicine 49
Replace Zhongming Zhang with:
Zhongming Zhang China
Zhaohua Zhang China
Xiaoliang Wang United States
Yingqiang Du China
Dina Xie United States
Jason M. Tanner United States
Miao Chen China
Shiyue Xu China
Zheyi Yan relative to Zhongming Zhang China Zhongming Zhang's profile →
Citations per field
00.5×3.5×
Zhongming Zhang · 1×
Citations per year

Countries citing papers authored by Zheyi Yan

Since Specialization
Citations

This map shows the geographic impact of Zheyi Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zheyi Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zheyi Yan more than expected).

Fields of papers citing papers by Zheyi Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zheyi Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zheyi Yan. The network helps show where Zheyi Yan may publish in the future.

Co-authorship network of co-authors of Zheyi Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Zheyi Yan. A scholar is included among the top collaborators of Zheyi Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zheyi Yan. Zheyi Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 0
2 19
3 10
4 12
5 22
6 20
7 25
8 33
9 8
10 98
11 43
12 47
13
Activation of δ-opioid receptors inhibits L-type Ca(2+) current and transient outward K(+) current in rat ventricular myocytes.
2

About Zheyi Yan

Zheyi Yan is a scholar working on Ophthalmology, Complementary and alternative medicine and Nephrology, having authored 13 papers that have together received 339 indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (4 papers), Adipokines, Inflammation, and Metabolic Diseases (3 papers) and Phytochemicals and Medicinal Plants (3 papers). The work is most often cited by research in Complementary and alternative medicine (49 citations), Cardiology and Cardiovascular Medicine (71 citations) and Epidemiology (106 citations). Zheyi Yan has collaborated with scholars based in China and United States. Frequent co-authors include Rui Guo, Yajing Wang, Wayne Bond Lau, Lu Gan, Xinliang Ma, Erhe Gao, Jianli Zhao, Wenjun Yan, Yongzhen Guo and G. William Wong. Their work appears in journals such as Circulation, PLoS ONE and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026